Abstract:Abstract Immunotherapies that modulate T cell function have been firmly established in cancer immunotherapy, whereas the potential for B cells in the antitumor immune response is not as well understood. B cell-activating factor (BAFF) is a cytokine belonging to the TNF ligand family that activates B cells and is linked to autoimmunity. Our preliminary research has identified BAFF as a target for enhancing antitumor immunity through enhancing presentation of tumor neoantigens and inducing tertiary lymphoid structures which can orchestrate tumor-specific T cell immune responses and correlate with improved clinical response. Since broad activation of B cell response could be detrimental and possibly induce autoimmune side effects, identification of specific B cell receptors that coordinate anti-tumor immunity is prudent. BAFF has three known receptors (BAFF-R, TACI and BCMA), and the effects of these specific BAFF ligand-receptor interactions on antitumor immunity are not known. Here we first generated BAFF-overexpressing cell lines using genomic editing [KPC-BAFF (pancreas), B16F10-BAFF (melanoma), and PancO2-BAFF (pancreas)] and examined their tumor growth in syngeneic immunocompetent host. Secondly, we investigated the effects of BAFF-overexpression on tumor response when individual receptors are knocked out using BAFF-R-KO, TACI-KO and BCMA-KO mice. Our results show significantly hindered tumor growth when the BAFF expressing stable cell lines are introduced to immunocompetent host, compared to parental cell lines. Tumor response experiments in receptor knockout mice is currently in progress. Successful identification of the BAFF receptor candidate that drives anti-tumor response is an exciting prospect for clinical translation. Development of agonists for the specific receptor may allow selective modulation of this particular B cell function in context of cancer therapy without perturbation of broad systemic humoral immunity. Citation Format: Khaled Aziz, Kabeer Munjal, Kathryn Howe, Mark Yarchoan. B-cell activating factor (BAFF) enhances antitumor immunity [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3978.

B Cell Activating Factor (baff) Induces the Transcription of Recombination-Activating Genes in Transitional Stage 1 B Cells

Baff Promotes Th17 Cells And Aggravates Experimental Autoimmune Encephalomyelitis

BAFF Binding to T Cell-Expressed BAFF-R Promotes Follicular Helper T Cell Proliferation and GC B Cell Responses

The Function of BAFF on T Helper Cells in Autoimmunity.

BAFF promotes follicular helper T cell development and germinal center formation through BR3 signal

Functions of B-cell-activating factor in autoimmune diseases

Contributions of each of the BAFF receptors to the lymphocyte profiles in C57BL/6 mice

Cutting Edge: Novel Function of B Cell-Activating Factor in the Induction of IL-10–Producing Regulatory B Cells

BAFF suppresses IL-15 expression in B cells.

B cell activating factor (BAFF) selects IL-10−B cells over IL-10+B cells during inflammatory responses

Humanized BAFF Transgenic Mice Develop Autoimmune Manifestations

Blockade of B-cell Activating Factor with TACI-IgG Effectively Reduced Th1 and Th17 Cells but Not Memory T Cells in Experimental Allergic Encephalomyelitis Mice

Abstract 3978: B-cell activating factor (BAFF) enhances antitumor immunity

Increased Targeting of Donor Switch Region and IgE in Sγ1-Deficient B Cells

B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF

Increased targeting of donor switch region and IgE in Sgamma1-deficient B cells.

[Role of B-cell-activating-factor in Immune Regulation--review].

B Cell-Activating Factor and Its Targeted Therapy in Autoimmune Diseases.

BAFF Binding to T Cell‐expressed BAFF‐R Costimulates T Cell Proliferation and Alloresponses

BAFFR activates PI3K/AKT signaling in human naive but not in switched memory B cells through direct interactions with B cell antigen receptors

Molecular Structure, Expression, and Bioactivity of B-cell-activating Factor of the TNF Family (BAFF) and Its Receptor BAFF-R in Cats (felis Catus).